Hints and tips:
Related Special Reports
...Cancer Research UK, which received £261mn in gifts from wills last year — its largest source of income — said the time taken to receive such funds had a “detrimental impact” on the charity “and our investment...
...The sector is seeing rapid growth that is outpacing much of the UK, said Joann Rhodes, head of the Health Innovation Research Alliance Northern Ireland....
...GHO has also previously invested in Sterling Pharma Solutions, a specialist in the development of antibody drug conjugates, a new kind of cancer drug, and acquired Belgian contract manufacturer Ardena in...
...A new venture, led by the founder of a biotech group that was sold to Sanofi for up to $1.45bn in 2021, has won £48mn in funding for research into cancer treatments using machine learning and genetically...
...’s lead author and a professor at the UK Institute of Cancer Research....
...“Early diagnosis needs to be connected to treatment or it is pointless,” said Nick James, professor at the UK Institute of Cancer Research and leader of the work on prostate cancer....
...This meant a significant proportion of cancer research was only possible because of public donations, she added....
...Pointing to the risks of unnecessary treatment, Cancer Research UK said over-diagnosis could have “a negative psychological impact”, and treatment of prostate cancer could also cause physical side effects...
...Research UK....
...Improvements in cancer survival have fallen sharply in recent years and progress is now slower than it has been for almost half a century, according to new data from Cancer Research UK....
...Nice said it did not approve Enhertu for metastatic breast cancer with low levels of HER2, a protein that promotes growth of cancer cells, after chemotherapy....
...In addition, the company said it was progressing towards US approval of an innovative cancer drug Datopotamab deruxtecan for the treatment of patients with advanced lung cancer....
...The charity Cancer Research UK welcomed the Johns Hopkins paper and the further evidence it offered about the promise of technologically assisted tumour detection....
...Just 38 per cent of all publicly funded cancer research in the UK comes from the government, the charity said, adding that the US government funds five times more cancer research “per capita” than the UK...
...Artificial intelligence has the power to sharply cut the number of missed early stage breast cancers, according to research that shows the technology’s potential to improve and accelerate medical diagnoses...
...The writer is executive director of the Global Antibiotic Research & Development Partnership Cancer survival rates have never been higher, but nor have the costs of treating cancer, with the escalating...
...“Subsequent diagnostic tests have identified a form of cancer,” Buckingham Palace added. The palace did not specify the form of cancer....
...Susan Galbraith, executive vice-president of oncology research and development at AstraZeneca, said there was an “opportunity to improve” on existing drugs in the area and that the Fusion acquisition would...
...It also deploys the broad powers of generative AI, rather than narrower capabilities tested in some previous AI medical studies such as diagnosing cancer risks from patient scans....
...Dementia Mission and chief executive of Alzheimer’s Research UK....
...for the death of his ex-wife, Nicole Brown, and her friend, Ronald Goldman....
...The UK aims to lead the world in research, development and innovation. To do so, we must address the woeful lack of research funding and poor outcomes for the less survivable cancers....
...The two said they plan to test the combination on other types of cancers, including lung cancer. Moderna boss Stéphane Bancel said he thinks the skin cancer vaccine could launch as early as 2025....
...cancers, the research showed....
International Edition